Derivo embolization device for intracranial aneurysms: a Spanish multicenter retrospective study
| Autor: | Carlos Piñana, Sebastian Remollo, Joaquín Zamarro, Mariano Werner, Mariano Espinosa de Rueda, Pedro Vega, David Hernandez, Eduardo Murias, Eila Rivera, Jorge Olier, Luis San Roman, Alfredo Páez-Carpio, Manuel Requena, Sonia Aixut, Marta de Dios Lascuevas, Manuel Moreu, Santiago Rosati, Laura Ludovica Gramegna, Carlos Castaño, Alejandro Tomasello |
|---|---|
| Rok vydání: | 2022 |
| Předmět: | |
| Zdroj: | Journal of NeuroInterventional Surgery r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol instname |
| ISSN: | 1759-8486 |
| Popis: | BackgroundFlow diverters have emerged in recent years as a safe and effective treatment for intracranial aneurysms, with expanding indications. The Derivo embolization device (DED) is a second-generation flow diverter with a surface finish that may reduce thrombogenicity. We report our multicenter experience evaluating its safety and efficacy.MethodsWe retrospectively analyzed all patients treated with the DED in eight centers in Spain between 2016 and 2020. Demographics, clinical data, procedural complications, morbidity and aneurysm occlusion rates were collected.ResultsA total of 209 patients with 250 aneurysms were treated (77.5% women). The majority of aneurysms were located in the internal carotid artery (86.8%) and most (69.2%) were small (ConclusionThe DED is a second-generation surface-modified flow diverter that presents an option for treatment of intracranial aneurysms with comparable safety and efficacy to other available flow diverter devices. Nonetheless, risks are not negligible, and must be balanced against the natural history risk of cerebral aneurysms, considering the tendency to widen indications for treatment of smaller and less complex lesions in day-to-day use. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|